- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03511144
A Comparison of Two Surgical Techniques Using the Unity Knee™ Total Knee System
November 20, 2018 updated by: Corin
A Prospective Randomised Double Blind Single Centre Study Comparing Measured Resection and Ligament Balancing Implantation Techniques Using the Unity Knee™ Total Knee System
A comparison of two Unity Knee™ tissue-balancing techniques by analysing the results from X-rays and patient questionnaires.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subjects suitable for the Unity Knee™ Total Knee System according to the product "Instructions for use"
- Over 18 years old
- Male and female subjects who are skeletally mature
- Subjects who have a smartphone (iOS or Android) with internet connection via mobile Internet data or Wi-Fi connection
- Subjects able to understand what is expected of them and be able to comply with the study protocol requirements
Exclusion Criteria:
- Any subject listed for a revision total knee replacement or conversion of a unicondylar replacement to a total knee replacement on the operative knee
- Any subject with fixed flexion contracture greater than 20 degrees
- Any subject with varus/valgus deformity greater than 15 degrees
- Any subject with confirmed osteoarthritis or other pathologies affecting the contralateral knee that is anticipated to require surgery within 12 months
- Any subjects with contralateral knee replacement that is anticipated to require revision surgery within 12 months
- Any subject whose prospects for a recovery to independent mobility would be compromised by known co-existent, medical problems
- Any subject with a known sensitivity to device material
- Any subject who is pregnant
- Any subject currently a prisoner
- Any subject known to be a drug or alcohol abuser, or have a psychological disorder that could affect follow-up care or treatment outcomes
- Any subject currently involved in any personal injury litigation, medical-legal or worker's compensations claims
- Any subject unable to read and understand English
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Measured resection
Total knee replacement using the Unity Knee™ implanted with the measured resection surgical technique
|
Total knee replacement using the Unity Knee™ implanted with the measured resection surgical technique
|
Active Comparator: Ligament balancing
Total knee replacement using the Unity Knee™ implanted with the ligament balancing surgical technique
|
Total knee replacement using the Unity Knee™ implanted with the ligament balancing surgical technique
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Posterior condylar offset (PCO)
Time Frame: 6 weeks post-op
|
Any difference in PCO from preoperative to 6 weeks post-surgery
|
6 weeks post-op
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Joint line in extension
Time Frame: 6 weeks post-op
|
Any difference in vertical distance from medial epicondyle to distal medial femoral condyle articular surface from preoperative to 6 weeks post-surgery
|
6 weeks post-op
|
Joint line in flexion
Time Frame: 6 weeks post-op
|
Any difference in medial joint line position measured using the PCO
|
6 weeks post-op
|
Femoral flexion angle
Time Frame: 6 weeks post-op
|
6 weeks post-op
|
|
Distal femoral component angle
Time Frame: 6 weeks post-op
|
6 weeks post-op
|
|
Tibial component angle
Time Frame: 6 weeks post-op
|
6 weeks post-op
|
|
Tibial slope
Time Frame: 6 weeks post-op
|
6 weeks post-op
|
|
Hip-knee-ankle (HKA) angle
Time Frame: 6 weeks post-op
|
6 weeks post-op
|
|
Oxford Knee Score (OKS)
Time Frame: Up to 24 months post-op
|
Up to 24 months post-op
|
|
Knee injury and Osteoarthritis Score - Physical Function Shortform (KOOS-PS)
Time Frame: Up to 24 months post-op
|
Up to 24 months post-op
|
|
EuroQoL 5-dimension health state (EQ-5D 5-level)
Time Frame: Up to 6 months post-op
|
Up to 6 months post-op
|
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: Up to 6 months post-op
|
Up to 6 months post-op
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
July 1, 2018
Primary Completion (Anticipated)
September 1, 2019
Study Completion (Anticipated)
July 1, 2020
Study Registration Dates
First Submitted
April 11, 2018
First Submitted That Met QC Criteria
April 24, 2018
First Posted (Actual)
April 27, 2018
Study Record Updates
Last Update Posted (Actual)
November 21, 2018
Last Update Submitted That Met QC Criteria
November 20, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CSP2015-04
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rheumatoid Arthritis
-
Janssen Research & Development, LLCWithdrawnActive Rheumatoid Arthritis; Rheumatoid Arthritis
-
Centocor, Inc.CompletedRheumatoid Arthritis, Juvenile
-
National Institute of Arthritis and Musculoskeletal...Children's Hospital Medical Center, CincinnatiCompleted
-
University of PittsburghNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedRheumatoid Arthritis | Juvenile Rheumatoid ArthritisUnited States
-
University of Missouri-ColumbiaCompletedJuvenile Rheumatoid ArthritisUnited States
-
AmgenTerminated
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedJuvenile Rheumatoid ArthritisUnited States
-
AmgenImmunex CorporationCompletedJuvenile Rheumatoid Arthritis
-
Universidad Autonoma de Nuevo LeonCompletedRheumatoId ArthritisMexico
-
Hamad Medical CorporationUnknownRHEUMATOID ARTHRITISQatar
Clinical Trials on Unity Knee™ TKR using measured resection
-
Peking University People's HospitalUnknown